EyePoint Pharmaceuticals logo
EyePoint Pharmaceuticals EYPT
$ 8.4 -6.2%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

EyePoint Pharmaceuticals Financial Statements 2011-2024 | EYPT

Annual Financial Statements EyePoint Pharmaceuticals

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

948 M 92.9 M 352 M 144 M 196 M 104 M 42.4 M 121 M 119 M 124 M 85.7 M 61.1 M 91.6 M

Shares

38.9 M 37.3 M 28.8 M 12.8 M 10.4 M 4.62 M 3.53 M 3.16 M 2.94 M 2.74 M 2.3 M 2.08 M 1.95 M

Historical Prices

24.4 2.49 12.2 6.58 15.5 18.9 10.8 17.1 48.2 41.1 39.7 12.1 11.1

Net Income

-70.8 M -102 M -58.4 M -45.4 M -56.8 M -53.2 M -18.5 M -21.5 M 6.35 M -13.4 M -11.9 M -24.8 M -8.63 M

Revenue

46 M 41.4 M 36.9 M 34.4 M 20.4 M 2.96 M 7.54 M 1.62 M 26.6 M 3.47 M 2.14 M 3.53 M 4.96 M

Cost of Revenue

- - - - - - - - - - - - -

Gross Profit

- - - 28.6 M 17.7 M - - - 26.6 M 3.47 M 2.14 M 3.53 M 4.96 M

Operating Income

-75.1 M -99.6 M -55.3 M -37.3 M -47.9 M -39 M -18.6 M -21.8 M 6.42 M -13.5 M -12 M -25.2 M -10 M

Interest Expense

1.25 M 3.19 M 5.5 M 7.26 M 6.18 M 2.36 M - - 22 K 5 K -2 K -1 K -13 K

EBITDA

-74.6 M -99.2 M -55 M -34.8 M -45.4 M -25.1 M -17.8 M -20.9 M 7.3 M -12.7 M -11 M -8.15 M -6.65 M

Operating Expenses

121 M 141 M 92.2 M 65.9 M 65.5 M 29.2 M 26.1 M 23.4 M 20.1 M 17 M 14.2 M 13.9 M 15 M

General and Administrative Expenses

40.1 M 34.8 M 25.6 M 20.7 M 17.9 M 11.5 M 11.2 M 9.01 M 8.06 M 7.47 M 7.17 M 6.87 M 8.1 M

All numbers in USD currency

Quarterly Income Statement EyePoint Pharmaceuticals

2024-Q3 2024-Q2 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

54.4 M 53.2 M 49 M 38.3 M 37.6 M 37.5 M 34.1 M 37.3 M 37.3 M 37.3 M 33.9 M 28.8 M 28.7 M 24.7 M 18.1 M 12.8 M 12.5 M 11.6 M 107 M 107 M 106 M 95.5 M 94.5 M 75.2 M 55.4 M 75.2 M 44.5 M 39.4 M 44.5 M 39.4 M 34.2 M 34.2 M 34.2 M 33.5 M 29.4 M 29.4 M 29.4 M 29.4 M 29.4 M 29.3 M 29.4 M 29.3 M 27 M 25.9 M 27 M 25.9 M 23.3 M 22.3 M 23.3 M 22.3 M 20.8 M 20.8 M 20.7 M 20.2 M

Net Income

-29.4 M -30.8 M - -12.6 M -22.9 M -21.2 M - -18.4 M -19.4 M -21 M - -16.7 M -10 M -12.3 M - -3.8 M -13 M -13.2 M -10.4 M -15.6 M -11.5 M -19.2 M -11.6 M -33.1 M -34.4 M -33.1 M -5.78 M -5.98 M -5.78 M -5.98 M -67 K -7.16 M -67 K -7.16 M -5.19 M -4.93 M -5.19 M -4.93 M -4.08 M 20.6 M -4.08 M 20.6 M -3.51 M -3.69 M -3.51 M -3.69 M -2.61 M -2.55 M -2.61 M -2.55 M -17.5 M -2.43 M -17.5 M -2.43 M

Revenue

10.5 M 9.48 M - 15.2 M 9.1 M 7.68 M - 10 M 11.6 M 9.29 M - 9.06 M 9.01 M 7.32 M - 15.7 M 4.12 M 7.49 M 8.63 M 2.51 M 7.21 M 2.01 M 2.44 M 486 K 715 K 928 K 933 K 385 K 1.32 M 590 K 5.97 M 277 K 5.97 M 277 K 526 K 466 K 526 K 466 K 521 K 25.3 M 521 K 25.3 M 592 K 597 K 592 K 597 K 585 K 553 K 585 K 553 K 630 K 1.66 M 630 K 1.66 M

Cost of Revenue

736 K 1.4 M - 1.2 M 1.79 M - - - - - - - - - - - - - - - 706 K 330 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Gross Profit

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Income

-32.7 M -34.5 M - -14.4 M -22.8 M -21.6 M - -18.4 M -19.2 M -18.3 M - -15.3 M -11 M -10.9 M - -1.96 M -11.2 M -11.4 M -8.98 M -14.1 M -10.2 M -14.7 M -11 M -13.6 M -9.78 M -13.6 M -5.81 M -6.01 M -5.81 M -6.01 M -94 K -7.19 M -94 K -7.19 M -5.24 M -4.98 M -5.24 M -4.98 M -4.12 M 20.8 M -4.12 M 20.8 M -3.54 M -3.72 M -3.54 M -3.72 M -2.65 M -2.59 M -2.65 M -2.59 M -17.6 M -2.53 M -17.6 M -2.53 M

Interest Expense

- - - - 435 K 812 K - 662 K 552 K 1.19 M - 1.39 M 1.38 M 1.35 M - 1.84 M 1.81 M 1.78 M - 1.77 M 1.6 M 1.02 M - 815 K 720 K 815 K 26 K - 49 K 23 K 27 K 24 K 27 K 24 K 10 K 10 K 10 K 10 K 3 K 3 K - - - -2 K - - -1 K -1 K -1 K -1 K - -2 K -2 K -2 K

EBITDA

- - - - - -21.4 M - -17.8 M -19.2 M -18.2 M - -15.1 M -10.4 M -10.9 M - -1.82 M -11.1 M -11.4 M -8.98 M -14 M -10.1 M -14.6 M -11 M -13.5 M -9.7 M -13.5 M -5.62 M -5.97 M -5.72 M -5.97 M 86 K -7.18 M -62 K -7.18 M -5.05 M -4.96 M -5.18 M -4.96 M -3.92 M 20.8 M -4.06 M 20.8 M -3.35 M -3.68 M -3.47 M -3.68 M -2.45 M -2.54 M -2.54 M -2.54 M -16.8 M -2.51 M -17.6 M -2.51 M

Operating Expenses

- - - 29.6 M 31.9 M 29.2 M - 28.4 M 30.8 M 27.6 M - 24.4 M 20 M 18.3 M - 17.7 M 15.3 M 18.9 M - 16.6 M 17.4 M 16.7 M - 14 M 10.5 M 14 M 6.74 M 6.39 M 13.1 M 6.39 M 6.06 M 7.46 M 6.06 M 7.46 M 5.76 M 5.45 M 5.76 M 5.45 M 4.64 M 4.52 M 4.64 M 4.52 M 4.13 M 4.32 M 4.13 M 4.32 M 3.23 M 3.14 M 3.23 M 3.14 M 18.3 M 4.19 M 18.3 M 4.19 M

General and Administrative Expenses

13 M 12.8 M - 10.6 M 9.06 M 9.24 M - 9.21 M 8.56 M 8.55 M - 6.06 M 5.18 M 5.12 M - 5.8 M 4.79 M 4.36 M - 4.36 M 4.82 M 4.61 M - 4.16 M 4.22 M 4.16 M 2.47 M 2.57 M 5.04 M 2.57 M 2.9 M 3.28 M 2.9 M 3.28 M 2.04 M 1.97 M 2.04 M 1.97 M 1.87 M 1.73 M 1.87 M 1.73 M 1.71 M 1.81 M 1.71 M 1.81 M 1.66 M 1.62 M 1.66 M 1.62 M 1.45 M 2.06 M 1.45 M 2.06 M

All numbers in USD currency